Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Mol Cell Probes ; 45: 89-93, 2019 06.
Artigo em Inglês | MEDLINE | ID: mdl-30885829

RESUMO

Single gene (Mendelian) disorders are one of the leading causes of neonatal morbidity and mortality. However, in the setting of preterm birth phenotypic features of genetic diseases are often undifferentiated and are clinically very difficult to interpret based on the wide range of differential diagnoses. We report an extremely low birth weight infant (ELBW) born prematurely at 23 + 0 gestational weeks after twin pregnancy with a novel clinical manifestation with persistent hyperglycaemia as well as the known manifestations of disease-associated hypokinesia, renal salt wasting, and multifocal atrial tachycardia. The patient died of heart failure on the 72nd day of life. Whole exome sequencing (WES) revealed a previously well established, disease-causing heterozygous likely pathogenic variant in the Harvey rat sarcoma viral oncogene homolog (HRAS)-gene (c.35G > C, p. G12A, rs104894230), which implied the clinical diagnosis of Costello syndrome (CS; OMIM#190020.0004). The twin brother merely had complications related to preterm birth and did not show any CS symptoms. In conclusion, our case illustrated that CS should be considered in ELBW infants showing a life-threatening combination of complex cardiac arrhythmia and hypokinesia. If a syndromic disorder is suspected in the neonatal intensive care unit (NICU) setting, rapid WES is a useful, non-invasive diagnostic tool in critically ill ELBW infants.


Assuntos
Sequenciamento do Exoma/métodos , Gravidez de Gêmeos/genética , Proteínas Proto-Oncogênicas p21(ras)/genética , Evolução Fatal , Feminino , Humanos , Recém-Nascido de Peso Extremamente Baixo ao Nascer/sangue , Recém-Nascido , Recém-Nascido Prematuro/sangue , Unidades de Terapia Intensiva Neonatal , Masculino , Polimorfismo de Nucleotídeo Único , Gravidez
2.
Kidney Int ; 83(6): 1144-9, 2013 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-23536130

RESUMO

About 75% of urinary stones contain oxalate. As Oxalobacter formigenes is a Gram-negative anaerobic bacterium that degrades oxalate in the intestinal tract, we assessed the role of O. formigenes in oxalate metabolism by evaluating its intestinal absorption, plasma concentration, and urinary excretion. Of 37 calcium oxalate stone formers, 26 tested negative for O. formigenes and were compared with the 11 patients who tested positive. Patients provided 24-h urine samples on both a self-selected and a standardized diet. Urinary oxalate excretion did not differ significantly on the self-selected diet, but was significantly lower in O. formigenes-positive than in O. formigenes-negative patients under controlled, standardized conditions. Intestinal oxalate absorption, measured using [(13)C2]oxalate, was similar in the patients with or without O. formigenes. Plasma oxalate concentrations were significantly higher in noncolonized (5.79 µmol/l) than in colonized stone formers (1.70 µmol/l). Colonization with O. formigenes was significantly inversely associated with the number of stone episodes. Our findings suggest that O. formigenes lowers the intestinal concentration of oxalate available for absorption at constant rates, resulting in decreased urinary oxalate excretion. Thus, dietary factors have an important role in urinary oxalate excretion. The data indicate that O. formigenes colonization may reduce the risk of stone recurrence.


Assuntos
Oxalato de Cálcio/metabolismo , Intestinos/microbiologia , Oxalobacter formigenes/metabolismo , Cálculos Urinários/microbiologia , Adulto , Idoso , Biomarcadores/sangue , Biomarcadores/urina , Oxalato de Cálcio/sangue , Oxalato de Cálcio/urina , Dieta , Feminino , Humanos , Absorção Intestinal , Mucosa Intestinal/metabolismo , Masculino , Pessoa de Meia-Idade , Oxalobacter formigenes/crescimento & desenvolvimento , Prevenção Secundária , Cálculos Urinários/metabolismo , Cálculos Urinários/prevenção & controle , Adulto Jovem
3.
Eur J Pediatr ; 171(10): 1541-7, 2012 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-22729246

RESUMO

UNLABELLED: The number of reports on baclofen intoxication has increased in recent years. We report a 15-year-old boy who was referred in a state of deep coma (Glasgow Coma Scale = 3). On clinical examination, he showed sinus bradycardia with normal blood pressure. On admission to the hospital, he presented intermittent short episodes of generalized tonic-clonic seizures. While results of imaging procedures and initial toxicological screening (including standard HPLC analysis and urine test) were negative, a nonconvulsive status epilepticus was diagnosed by electroencephalography (EEG). Identification of baclofen as causative agent was possible after the boy's father reported abusive baclofen intake. Subsequent toxicological target analysis of blood and urine samples confirmed the excessive intake of baclofen and showed a typical elimination pattern with a secondary release. Following 112 h of mechanical ventilation, the boy rapidly regained consciousness and recovered normal neurological behavior. CONCLUSIONS: The present case demonstrates the importance of considering baclofen overdosage in cases of severe coma in combination with an abnormal EEG pattern and sinus bradycardia with normal blood pressure levels, in particular as the substance is popular in internet reports promoting baclofen as a rather harmless "fun drug." Furthermore, it underlines the difficulty to identify baclofen as a causative agent without anamnestic information. Nevertheless, by reviewing existing literature on oral baclofen overdosage, it is possible to picture a nearly specific pattern of clinical symptoms in baclofen intoxication.


Assuntos
Baclofeno/efeitos adversos , Coma/induzido quimicamente , Overdose de Drogas/diagnóstico , Relaxantes Musculares Centrais/sangue , Estado Epiléptico/induzido quimicamente , Adolescente , Baclofeno/sangue , Baclofeno/urina , Bradicardia/induzido quimicamente , Humanos , Masculino , Relaxantes Musculares Centrais/urina , Convulsões/induzido quimicamente
4.
Neonatology ; 113(1): 81-88, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-29131022

RESUMO

BACKGROUND: Pulmonary hypertension (PH) affects 1 in 6 infants with a birthweight <1,000 g (extremely low birthweight; ELBW) and is frequently associated with bronchopulmonary dysplasia (BPD). If untreated, the mortality rates of the disease are high. OBJECTIVES: The aim of this study was to characterize risk factors for PH in ELBW infants and to describe the timing of onset of the disease by setting up a screening program. METHODS: ELBW infants treated at the Department of Neonatology (level III neonatal intensive care unit at the University of Cologne Medical Centre, Germany) between January 2010 and March 2015 were included. Echocardiography screening for PH was performed either before discharge or if BPD was diagnosed. Additionally, infants had at least 1 echocardiographic scan after discharge. Survival with PH, age at diagnosis of PH, and risk factors associated with PH were assessed. RESULTS: In total, 34/188 (18%) infants had PH. Of these, 14 (41%) were identified after discharge. Another 11 (32%) were diagnosed with PH without suffering from moderate or severe BPD. The risk factors for diagnosis of PH were moderate (odds ratio, OR 4 [2-8]) or severe BPD (OR 13 [2-71]), prolonged rupture of membranes >7 days (OR 5 [1-19]), and birthweight below the 3rd percentile (OR 3 [1-9]). All infants with PH before discharge and 50% diagnosed after discharge were treated with sildenafil (2.0 mg/kg/day). PH resolved and sildenafil was discontinued in all patients after a median duration of 13 months (IQR 8-20). CONCLUSIONS: An echocardiographic screening program may help to identify infants with PH. Examinations should include all ELBW infants irrespective of the presence of BPD and be continued after discharge.


Assuntos
Displasia Broncopulmonar/fisiopatologia , Hipertensão Pulmonar/diagnóstico por imagem , Hipertensão Pulmonar/tratamento farmacológico , Recém-Nascido de Peso Extremamente Baixo ao Nascer , Citrato de Sildenafila/administração & dosagem , Peso ao Nascer , Displasia Broncopulmonar/complicações , Ecocardiografia , Feminino , Alemanha , Idade Gestacional , Humanos , Hipertensão Pulmonar/etiologia , Lactente , Recém-Nascido , Unidades de Terapia Intensiva Neonatal/organização & administração , Modelos Logísticos , Masculino , Fatores de Risco , Índice de Gravidade de Doença
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA